Audible Bleeding team Matt Chia (@chia_md) and Gowri Gowda (@GowriGowda11) are joined by the co-principle investigators of the BEST-CLI trial, Dr. Matthew Menard and Dr. Alik Farber. We talk about the results of BEST-CLI, marking what is sure to be the next landmark trial in vascular surgery. Drs. Menard and Farber give their insights on being clinical trialists and surgeons in the modern era, reflecting on challenges in conducting this work and its broad-reaching implications.
- Dr. Matthew Menard (@MattMenard6) is the program director for the vascular and endovascular fellowship program and co-director of the Endovascular Surgery Program at Brigham and Women’s Hospital. He is a vascular and endovascular surgeon at BWH and an Associate Professor of Surgery at Harvard Medical School.
- Dr. Alik Farber is the Chief of the Division of Vascular and Endovascular Surgery at Boston Medical Center and Professor of Surgery and Radiology at Boston University School of Medicine
Follow us @AudibleBleeding
Learn more about us at https://www.audiblebleeding.com/about-1/ and #jointheconversation.